Fortune.com – August 25, 2016
Mylan NV said it would reduce the patient cost of its severe allergy treatment drug EpiPen on Thursday, a day after Democratic Presidential candidate Hillary Clinton called for lower pricing of the drug.
Sometimes it’s healthful when,
“The sword is mightier than the pen.”
“The sword is mightier than the pen.”